United Services Automobile Association Glycomimetics Inc Transaction History

United Services Automobile Association

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$2.8 - $12.85 $335,952 - $1.54 Million	-119,983 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$10.6 - $13.12 $11,289 - $13,972	1,065 Added 0.9%	119,983 $1.43 Million
Q4 2018 Feb 13, 2019	SELL	$8.47 - $14.71 $92,195 - $160,118	-10,885 Reduced 8.39%	118,918 $1.13 Million
Q3 2018 Nov 13, 2018	SELL	$13.7 - $17.12 $18,138 - $22,666	-1,324 Reduced 1.01%	129,803 $1.87 Million
Q2 2018 Sep 27, 2018	BUY	$14.63 - $19.19 $1.63 Million - $2.14 Million	111,642 Added 572.96%	131,127 $2.12 Million
Q2 2018 Aug 10, 2018	SELL	$14.63 - $19.19 $1.6 Million - $2.09 Million	-109,138 Reduced 84.85%	19,485 $159,000
Q1 2018 May 14, 2018	BUY	$16.06 - $25.35 $872,250 - $1.38 Million	54,312 Added 73.09%	128,623 $2.09 Million
Q4 2017 Feb 14, 2018	BUY	$10.51 - $17.22 $25,003 - $40,966	2,379 Added 3.31%	74,311 $1.25 Million
Q3 2017 Nov 14, 2017	BUY	$10.14 - $14.85 $729,390 - $1.07 Million	71,932	71,932 $1.01 Million

27.3M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $15.2M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.